GBM presents as one of the two subtypes phosphate and tensin homolog(PTEN, epidermal growth factor receptor (EGFR), ink4a/Arf or p53, platelet derived growth factor (PDGF) mutant) that have distinct molecular profiles and present distinct clinical signatures [20]. This evidence concerns the gene EGFR and glioblastoma.